Multiple Ascending Dose Phase 1 Study of ALA-3000

Clinical trial NCT06965569 · COMPLETED

Trial details

NCT number: NCT06965569
Sponsor: Alar Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Treatment Resistant Depression

Start date: 2025-04-21
Primary completion: 2025-12-30
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.